Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection

INDIANAPOLIS, Sept. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a fully automated assay for the detecti... Diagnostics, FDA Roche Group, Treponema, syphilis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news